# Phase 3 scope: the radical SAM reviews that already existed when this project
# started, and that the Phase 3 consistency pass brought into line with the
# treatment rule in projects/RADICAL_SAM.md.
#
# These genes are deliberately NOT in the project page's `genes:` frontmatter, so
# they do not enter the Phase 4 synthesis totals: Phase 4 reports what this
# project reviewed from scratch. They are listed here instead so that
# rsam_synthesis.py can check the treatment rule across them too, which is what
# makes the Phase 3 claim verifiable rather than asserted.
#
# Entries are organism-qualified because several symbols (lipA, bioB, moaA, hemN,
# pqqE) exist in more than one organism directory. human/MOCS1 is absent here
# because it IS in the Phase 4 scope and is checked there.
genes:
- BACSU/lipA
- METEA/pqqE
- POPTR/LIP1
- POPTR/LIP1P-1
- POPTR/LIP1P-2
- PSEPK/PP_1969
- PSEPK/PP_2482
- PSEPK/bioB
- PSEPK/hemN
- PSEPK/lipA
- PSEPK/moaA
- PSEPK/pqqE
- SACEN/eryCV
- SCHPO/bio2
- STAWA/cfr
- yeast/BIO2